Manatt Health counsel Adam Finkelstein spoke with Modern Healthcare about the administration’s recent executive order, which called on the HHS secretary to create rules to tie Medicare outpatient drug payment to international prices. In the article, Finkelstein discussed the pathways that the administration could take to make changes to its Part B policy, and the challenges that it might face in expediting the process, saying “they have a couple of pathways, and not all are guaranteed to work.” He also notes that the quicker the administration moves forward the more vulnerable they are going to make themselves to legal challenges.